Distinct temporal patterns of immediate asthmatic reactions due to high- and low-molecular-weight agents

Clinical and Experimental Allergy

Volumn 42, Issue 7, 2012, Pages 1021-1027

  Malo, J L ^a   Ghezzo, H ^a   L'Archeveque J ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Asthmatic reactions; Bronchial hyperresponsiveness; Occupational asthma; Specific inhalation challenges

Indexed keywords

ADULT; ARTICLE; ATOPY; CORTICOSTEROID THERAPY; DELAYED HYPERSENSITIVITY; DISEASE DURATION; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMOKING;

ADULT; ALLERGENS; ASTHMA, OCCUPATIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OCCUPATIONAL EXPOSURE;

EID: 84862580098     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03970.x     Document Type: Article

References (29)

1. Pepys J. Inhalation challenge tests in asthma. New Engl J Med 1975; 293:758-9.
2. Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol 1952; 3:323-8.
3. Colldahl H. A study of provocation test on patients with bronchial asthma. Acta Allergol 1952; 5:133-42.
4. Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 112:829-59.
5. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995; 333:107-12.
6. Chinen J, Fleisher TA, Shearer WT. The immune system: an overview. In: Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FER eds. Middleton's Allergy. Philadelphia: Mosby Elsevier, 2009: 3-17.
7. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002; 57:231-6.
8. Lemière C, Romeo P, Chaboillez S, Tremblay C, Malo JL. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002; 110:641-6.
9. Vandenplas O, Malo JL. Inhalation challenges with agents causing occupational asthma. Eur Respir J 1997; 10:2612-29.
10. Vandenplas O, Cartier A, Malo JL. Occupational Challenge Tests. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI eds. Asthma in the Workplace. New York: Taylor & Francis, 2006:227-52.
11. Malo JL, Cartier A, Lemière C et al. Exaggerated bronchoconstriction due to inhalation challenges with occupational agents. Eur Respir J 2004; 23:300-3.
12. Caron S, Boileau JC, Malo JL, Leblond S. New methodology for specific inhalation challenges with occupational agents. Respir Res 2010; 11:72.
13. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-43.
14. Malo JL, Pineau L, Cartier A, Martin RR. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one-second in a normal population. Am Rev Respir Dis 1983; 128:8-11.
15. Pizzichini MMM, Popov TA, Efthimiadis A et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:866-9.
16. Lemière C, Pizzichini MMM, Balkissoon R et al. Diagnosing occupational asthma: use of induced sputum. Eur Respir J 1999; 13:482-8.
17. Dehaut P, Rachiele A, Martin RR, Malo JL. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax 1983; 38:516-22.
18. Cullinan P. Occupational asthma, IgE and IgG. Clin Exp Allergy 1998; 28:668-70.
19. Lemière C, Biagini RE, Zeiss CR. Immunological and inflammatory assessments. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI eds. Asthma in the workplace. New York: Taylor & Francis, 2006:179-97.
20. Cartier A, Grammer L, Malo JL et al. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 1989; 84:507-14.
21. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor by peripheral monocuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998; 102:265-74.
22. Bernstein DI, Cartier A, Cote J et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002; 166:445-50.
23. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998; 101:709-15.
24. Park HS, Kim HY, Nahm DHo, Son JW, Kim YY. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocations test results. J Allergy Clin Immunol 1999; 104:847-51.
25. Park HS, Lee SK, Lee YM, Kim SS, Nahm DH. Longitudinal study of specific antibodies to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate in patients with TDI-induced asthma. Korean J Internal Med 2002; 17:249-51.
26. Malo JL, L'Archevêque J, Lummus Z, Bernstein D. Changes in specific IgE and IgG and monocyte chemoattractant protein-1 in workers with occupational asthma caused by diisocyanates and removed from exposure. J Allergy Clin Immunol 2006; 118:530-3.
27. Park HS, Hong CS. The significance of specific IgG and IgG4 antibodies to a reactive dye in exposed workers. Clin Exp Allergy 1991; 21:357-62.
28. Cartier A, Thomson NC, Frith PA, Roberts R, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982; 70:170-7.
29. Malo JL, Ghezzo H, L'Archevêque J, Cartier A. Late asthmatic reactions to occupational sensitizing agents: frequency of changes in nonspecific bronchial responsiveness and of response to inhaled beta-2 adrenergic agent. J Allergy Clin Immunol 1990; 85:834-42.